Pharmacy Medical News about Cannabis Pain Therapeutics

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State
Journal of Opioid Management, 11/03/09

Aggarwal SK et al. – Of 139 patients, 15 (11%) had prior authorizations for MC before seeking care in this clinic. The sample contained 236.4 patient years of authorized MC use. Time of authorized use ranged from 11 days to 8.31 years (median of 1.12 years). Most patients were male (63%) yet female patients averaged 0.18 years longer authorized use. There were no other gender–specific trends or factors. Most patients (n = 123, 88%) had more than one pain syndrome present. Myofascial pain syndrome was the most common diagnosis (n = 114, 82%), followed by neuropathic pain (n = 89, 64%), discogenic back pain (n = 72, 51.7%), and osteoarthritis (n = 37, 26.6%). Other diagnoses included diabetic neuropathy, central pain syndrome, phantom pain, spinal cord injury, fibromyalgia, rheumatoid arthritis, HIV neuropathy, visceral pain, and malignant pain. In 51 (37%) patients, there were documented instances of major hurdles related to accessing MC, including prior physicians unwilling to authorize use, legal problems related to MC use, and difficulties in finding an affordable and consistent supply of MC.

<< Previous
Systematic Review: Comparative Effectiveness and Harms of...

Next >>
Dual antiplatelet therapy in coronary artery disease: A...

The pharmacological treatment of neuropathic pain
European Journal of Pain, 11/12/09 Relevance Score: 69%

Genetic modulation of the pharmacological treatment of pain
Pharmacology & Therapeutics, 11/06/09 Relevance Score: 68%

Pain Catastrophizing and Salivary Cortisol Responses to Laboratory Pain Testing in Temporomandibular Disorder and Healthy Participants
The Journal of Pain, 10/26/09 Relevance Score: 68%

Treatment of Herpes Zoster and Postherpetic Neuralgia
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 10/19/09 Relevance Score: 68%

A phenotypically restricted set of primary afferent nerve fibers innervate the bone versus skin: Therapeutic opportunity for treating skeletal pain
Bone, 10/16/09 Relevance Score: 68%